Filippo Pietrantonio, MD, discusses findings from the phase 1/2 OrigAMI-1 study in RAS/BRAF wild-type mCRC.
Filippo Pietrantonio, MD
Advertisement
Filippo Pietrantonio, MD, is a medical oncologist at the National Cancer Insitute of Milan, Italy.
Articles by Filippo Pietrantonio, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
House Votes to Extend ACA Subsidies, Eyes Turn to Senate
2
5 Key Health Care Changes During Trump’s First Year Back in Office
3
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
4
Early Stable Disease in BTC Predicts Improved Survival With Zanidatamab
5
